Advanced Search
Maren Bodenhausen, Jonas Geisperger, Julia Lange de Luna, Johannes Wendl, Alexander Hapfelmeier, Lina Schulte-Hillen, Rafael Pricoco, Nina Koerber, Tanja Bauer, Josef Mautner, Dieter Hoffmann, Peter Luppa, Silvia Egert-Schwender, Elfriede Noessner, Henri-Jacques Delecluse, Susanne Deleculse, Fabian Hauck, View ORCID ProfileChristine S. Falk, Thomas Schulz, Marc-Matthias Steinborn, Andreas Bietenbeck, Alexandra Nieters, View ORCID ProfileLorenz Mihatsch, Katrin Gerrer, Uta Behrends, IMMUC Study Group
doi: https://doi.org/10.1101/2024.05.17.24307333
- Abstract
- Info/History
- Metrics
- Supplementary material
- Data/Code
- Preview PDF
Abstract
Background: Epstein-Barr virus-associated Infectious Mononucleosis (EBV-IM) is a common disease following primary EBV infection in children and adolescents. While EBV-IM is mostly self-limiting, symptoms like fatigue may persist over several months or even result in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This large clinical observational study aimed at identifying risk factors for protracted courses of EBV-IM in young people.Methods: A cohort of N=200 children, adolescents, and young adults with acute primary EBV infection was recruited from hospitals and private practices. Data on the patients' medical history as well as clinical and laboratory parameters were collected at a baseline visit (V1) within four weeks after symptom onset (Tonset) and at two follow-up visits (V2 and V3) one and six months after Tonset. Risk factors for protracted symptoms at V3 were modeled using multivariable logistic regressions.Results: Protracted symptoms were observed in 55/183 (30.1%) and protracted fatigue in 34/181 (18.8%) patients at V3. A medical history indicating an increased susceptibility to infectious diseases as well as distinct severe IM symptoms, e.g. severe gastrointestinal symptoms, were significantly associated with protracted disease [OR: 2.31; P=0.011 and OR: 3.42; P=0.027] and with chronic fatigue [OR: 2.98; P=0.006 and OR: 3.54; P=0.034], respectively. Occurrence of twelve or more clinical and laboratory parameters until and including V1 discriminated between fatigue and no fatigue at V3 [OR 2.43, P=0.033].Conclusion: A clinical history of immune dysregulation as well as distinct severe IM symptoms might predict protracted post-viral disease and thus help in the identification of young patients at risk.
Competing Interest Statement
A.B. received lecture fees from Siemens. U.B. received research grants for ME/CFS or EBV studies from the Federal Ministry of Education and Research, the Federal Ministry of Health, the Bavarian State Ministry of Health and Care, the Bavarian State Ministry of Science and the Arts, the German Center for Infection Research, the People for Children (Menschen fuer Kinder) foundation, the Weidenhammer-Zoebele Foundation, the Lost Voices Foundation, and the ME/CFS research foundation. All other authors have no conflict of interest to declare.
Funding Statement
The German Center for Infection Research (DZIF) (grant numbers 07_905 and 07_909). Funding was acquired by U.B. and received by P.L., S.E-S., A.H., D.H., F.H., J.M., T.B., H-J.D., C.F., and T.S..
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the TUM School of Medicine and Health of the Technical University of Munich in Germany gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study is not openly available.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
PostedMay 17, 2024.
Download PDF
Supplementary Material
Data/Code
Citation Tools
- Facebook Like
- Google Plus One
Subject Areas
All Articles
Addiction Medicine (324)
Allergy and Immunology (628)
Anesthesia (165)
Cardiovascular Medicine (2377)
Dentistry and Oral Medicine (289)
Dermatology (207)
Emergency Medicine (379)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (837)
Epidemiology (11775)
Forensic Medicine (10)
Gastroenterology (703)
Genetic and Genomic Medicine (3744)
Geriatric Medicine (350)
Health Economics (634)
Health Informatics (2399)
Health Policy (933)
Health Systems and Quality Improvement (898)
Hematology (341)
HIV/AIDS (782)
Infectious Diseases (except HIV/AIDS) (13318)
Intensive Care and Critical Care Medicine (767)
Medical Education (365)
Medical Ethics (105)
Nephrology (398)
Neurology (3507)
Nursing (198)
Nutrition (526)
Obstetrics and Gynecology (674)
Occupational and Environmental Health (664)
Oncology (1824)
Ophthalmology (538)
Orthopedics (219)
Otolaryngology (287)
Pain Medicine (233)
Palliative Medicine (66)
Pathology (446)
Pediatrics (1035)
Pharmacology and Therapeutics (426)
Primary Care Research (420)
Psychiatry and Clinical Psychology (3178)
Public and Global Health (6145)
Radiology and Imaging (1280)
Rehabilitation Medicine and Physical Therapy (747)
Respiratory Medicine (828)
Rheumatology (379)
Sexual and Reproductive Health (372)
Sports Medicine (323)
Surgery (402)
Toxicology (50)
Transplantation (172)
Urology (146)
